Phase 2 Partners’s Carlyle Group CG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.23M Sell
63,887
-108,023
-63% -$5.48M 2.42% 18
2024
Q3
$7.4M Buy
+171,910
New +$7.21M 4.37% 7
2024
Q2
Sell
-107,830
Closed -$5.06M 32
2024
Q1
$5.06M Buy
+107,830
New +$4.66M 2.64% 20
2023
Q1
Sell
-482,557
Closed -$14.4M 31
2022
Q4
$14.4M Buy
482,557
+111,057
+30% +$3.17M 6.5% 6
2022
Q3
$9.6M Buy
371,500
+58,046
+19% +$1.91M 4.56% 6
2022
Q2
$9.92M Buy
+313,454
New +$12M 5.1% 6
2022
Q1
Sell
-109,818
Closed -$6.03M 23
2021
Q4
$6.03M Buy
+109,818
New +$5.98M 3.73% 12

Other funds holding CG

Phase 2 Partners's CG Position: Q4 2024 in Review

Phase 2 Partners reduced its Carlyle Group (CG) stake by 63% in Q4 2024, selling an estimated $5.48M and leaving 63,887 shares worth $3.23M. The position accounts for 2.42% of the portfolio, ranked #18.

Phase 2 Partners first reported a position in CG in Q4 2021 and has held it in 7 quarters since. The position peaked at $14.4M in Q4 2022. 566 funds tracked by Wall St. Rank hold CG as of Q4 2024.

  • Phase 2 Partners held 63,887 shares of Carlyle Group worth $3.23M as of Q4 2024.
  • Phase 2 Partners sold 108,023 Carlyle Group shares in Q4 2024, an estimated $5.48M.
  • Carlyle Group made up 2.42% of Phase 2 Partners's portfolio in Q4 2024, its #18 holding.
  • Phase 2 Partners first reported a position in Carlyle Group in Q4 2021 and has held it in 7 quarters since.
  • Phase 2 Partners's Carlyle Group position peaked at $14.4M in Q4 2022.
  • 566 funds tracked by Wall St. Rank held Carlyle Group as of Q4 2024.

Based on Phase 2 Partners's 13F filing for Q4 2024, filed 14 Feb 2025.